Aesica Queenborough Limited
NDC Database

Aesica Queenborough Limited

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing
  • Total Records 6
  • Latest Marketing Date 2017-11-29
  • Data Source FDA
  • First Marketing Date 2011-02-01
Company Overview

Company

Aesica Queenborough Limited

Country

United Kingdom

Website

Visit Website

Email

Social Profiles

Company Snapshot

Aesica Queenborough Limited

Head Office Q5, Quorum Business Park Benton Lane Newcastle upon Tyne NE12 8BS United Kingdom

United Kingdom

www.recipharm.com/ View on Map
NDC Records ( 6 records )
2011
01 Feb
Drug for Further Processing NDC: 43798-001

Nonproprietary Name

Metformin Hydrochloride and Sitagliptin Phosphate

Dosage Form

TABLET, FILM COATED

Strength

850; 50 mg/1; mg/1

Labeler

Aesica Queenborough Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

43798-001

Substance

METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2011-02-01

End Marketing Date

2027-03-29

Listing Record Certified Through

-

2011
17 Jun
Drug for Further Processing NDC: 43798-002

Nonproprietary Name

Metformin Hydrochloride and Sitagliptin Phosphate

Dosage Form

TABLET, FILM COATED

Strength

500; 50 mg/1; mg/1

Labeler

Aesica Queenborough Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

43798-002

Substance

METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2011-06-17

End Marketing Date

2027-03-08

Listing Record Certified Through

-

2011
17 Jun
Drug for Further Processing NDC: 43798-003

Nonproprietary Name

Metformin Hydrochloride and Sitagliptin Phosphate

Dosage Form

TABLET, FILM COATED

Strength

1000; 50 mg/1; mg/1

Labeler

Aesica Queenborough Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

43798-003

Substance

METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2011-06-17

End Marketing Date

2027-03-01

Listing Record Certified Through

-

2015
17 Feb
Drug for Further Processing NDC: 43798-004

Nonproprietary Name

Lumacaftor and Ivacaftor

Dosage Form

TABLET, FILM COATED

Strength

125; 200 mg/1; mg/1

Labeler

Aesica Queenborough Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

43798-004

Substance

IVACAFTOR; LUMACAFTOR

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2015-02-17

End Marketing Date

2027-03-31

Listing Record Certified Through

-

2015
17 Feb
Drug for Further Processing NDC: 43798-005

Nonproprietary Name

Ivacaftor

Dosage Form

TABLET, FILM COATED

Strength

150 mg/1

Labeler

Aesica Queenborough Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

43798-005

Substance

IVACAFTOR

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2015-02-17

End Marketing Date

2027-02-28

Listing Record Certified Through

-

2017
29 Nov
Drug for Further Processing NDC: 43798-014

Nonproprietary Name

Lumacaftor/Ivacaftor Paediatric

Dosage Form

TABLET, FILM COATED

Strength

125; 100 mg/1; mg/1

Labeler

Aesica Queenborough Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

43798-014

Substance

IVACAFTOR; LUMACAFTOR

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2017-11-29

End Marketing Date

2026-10-31

Listing Record Certified Through

-

Related Databases
  • FDA Inspections
    7 View
  • EDQM CEP
    1 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    6 View
  • FDA Approved Drugs Database
    0 View
NDC Type Breakdown
6 total
  • Drug for Further Processing
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

43798-001

Nonproprietary Name

Metformin Hydrochloride and Sitagliptin Phosphate

Labeler

Aesica Queenborough Limited

Dosage Form

TABLET, FILM COATED

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit